Abiraterone, Apalutamide, Enzalutamide or Darolutamide (ARPI therapy) (per standard of care) therapy clinical trials

Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

This study looks at treating advanced prostate cancer with hormone tablets. Researchers want to see if a lower dose works as well as the standard dose, with fewer side effects like tiredness. It aims to improve quality of life for patients.